Michael Brada

Q: What Schools Are Affiliated With Michael Brada

Michael Brada is affiliated with the following schools: University of Liverpool, University of Glasgow

Michael Brada's AcademicInfluence.com Rankings

Michael Brada

Philosophy

#8791

World Rank

#12238

Historical Rank

Logic

#5810

World Rank

#7250

Historical Rank

philosophy Degrees

Michael Brada

Biology

#11960

World Rank

#15402

Historical Rank

Neuroscience

#1981

World Rank

#2037

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Michael Brada's Degrees

Doctorate Medicine Stanford University

Why Is Michael Brada Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael Brada's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse (2000) (932)
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. (1999) (654)
Pathology and Genetics of Tumours of the Nervous System (2001) (639)
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014) (507)
Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. (1992) (415)
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. (2001) (373)
Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. (2005) (365)
The long‐term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas (1993) (356)
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO) (2017) (312)
Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial (2002) (297)
Craniopharyngioma--a long-term results following limited surgery and radiotherapy. (1993) (281)
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. (2003) (271)
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires (1996) (265)
ESTRO-ACROP guideline "target delineation of glioblastomas". (2016) (252)
Relocatable frame for stereotactic external beam radiotherapy. (1991) (244)
Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma. (2010) (213)
Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma (1997) (210)
The use of significant others as proxy raters of the quality of life of patients with brain cancer. (1997) (208)
The incidence of cerebrovascular accidents in patients with pituitary adenoma. (1999) (202)
Glioma (2015) (202)
Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. (2000) (202)
Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies (1999) (199)
Proton therapy in clinical practice: current clinical evidence. (2007) (199)
Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. (1997) (181)
Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. (2013) (178)
Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial. (2001) (175)
Effect of disease burden on health-related quality of life in patients with malignant gliomas. (2000) (167)
Growth hormone treatment of children with brain tumors and risk of tumor recurrence. (2000) (160)
A medical research council randomized trial in patients with primary cerebral non‐Hodgkin lymphoma (2000) (159)
Precision oncology: origins, optimism, and potential. (2016) (158)
Radiotherapy in the treatment of benign meningioma of the skull base. (1999) (158)
Cerebrovascular mortality in patients with pituitary adenoma (2002) (151)
Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. (1996) (148)
Postoperative radiotherapy in the management of spinal cord ependymoma. (1991) (146)
Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. (1992) (145)
Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas (2006) (129)
Dose escalation for non-small cell lung cancer: analysis and modelling of published literature. (2011) (122)
A Comparison of clinical target volumes determined by CT and MRI for the radiotherapy planning of base of skull meningiomas. (2000) (118)
Charged particles in radiotherapy: a 5-year update of a systematic review. (2012) (118)
Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma (1997) (118)
Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. (2007) (113)
Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. (1991) (111)
The incorporation of SPECT functional lung imaging into inverse radiotherapy planning for non-small cell lung cancer. (2005) (105)
Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study). (1993) (101)
Comparison of intensity-modulated tomotherapy with stereotactically guided conformal radiotherapy for brain tumors. (1999) (101)
The role of prophylactic spinal irradiation in localized intracranial ependymoma. (1991) (99)
Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone. (1990) (99)
A non-invasive, relocatable stereotactic frame for fractionated radiotherapy and multiple imaging. (1991) (99)
Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy (2004) (99)
Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. (1989) (94)
Somnolence syndrome in adults following cranial irradiation for primary brain tumours. (1998) (91)
Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide. (2000) (87)
Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood. (2002) (87)
A phase I/II trial of PTK787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor, in combination with either temozolomide or lomustine for patients with recurrent glioblastoma multiforme (GBM). (2004) (86)
Thalidomide as an Anti-angiogenic Agent in Relapsed Gliomas (2004) (84)
Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma. (1995) (81)
A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer. (2007) (80)
Evaluation of a nurse-led telephone clinic in the follow-up of patients with malignant glioma. (2000) (80)
Current Clinical Evidence for Proton Therapy (2009) (78)
Stereotactic radiotherapy of irregular targets: a comparison between static conformal beams and non-coplanar arcs. (1993) (78)
Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours. (1989) (78)
Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL). (1998) (78)
Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma (1994) (78)
ChlVPP combination chemotherapy for Hodgkin's disease: long-term results. (1990) (77)
Feasibility of the use of the Active Breathing Co ordinator (ABC) in patients receiving radical radiotherapy for non-small cell lung cancer (NSCLC). (2009) (77)
Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters. (2008) (73)
Modern techniques for pituitary radiotherapy (2009) (73)
Who should follow up cancer patients? Nurse specialist based outpatient care and the introduction of a phone clinic system. (1994) (73)
Radiosurgery for pituitary adenomas (2004) (73)
Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy. (1994) (72)
Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer. (2007) (71)
Optimization of stereotactically-guided conformal treatment planning of sellar and parasellar tumors, based on normal brain dose volume histograms. (1999) (70)
Treatment of lung cancer using volumetric modulated arc therapy and image guidance: A case study (2008) (65)
Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls. (2003) (65)
Quality assurance in fractionated stereotactic radiotherapy. (1994) (63)
High precision focused irradiation in the form of fractionated stereotactic conformal radiotherapy (SCRT) for benign meningiomas predominantly in the skull base location. (2002) (63)
Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy (1994) (62)
A comparison of techniques for stereotactic radiotherapy by linear accelerator based on 3-dimensional dose distributions. (1991) (62)
The management of histologically unverified presumed cerebral gliomas with radiotherapy. (1994) (62)
Is there a need to follow-up cancer patients? (1995) (61)
Management of spinal astrocytoma with conservative surgery and radiotherapy. (1993) (61)
Radiotherapy for the treatment of recurrent craniopharyngioma. (1992) (60)
Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration. (1999) (59)
Stereotactically guided conformal radiotherapy for meningiomas. (1999) (58)
Long-term efficacy of fractionated radiotherapy for benign meningiomas. (2013) (56)
Non-Hodgkin's lymphoma presenting with extradural spinal cord compression: functional outcome and survival. (1991) (54)
Treatment accuracy of fractionated stereotactic radiotherapy. (2005) (54)
Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer. (2005) (52)
Could assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value? (2003) (52)
Somnolence syndrome in patients receiving radical radiotherapy for primary brain tumours: a prospective study. (2011) (51)
Craniopharyngioma: improving outcome by early recognition and treatment of acute complications. (1997) (48)
Combining immunotherapy and radiotherapy in lung cancer. (2018) (48)
The use of the Active Breathing Coordinator throughout radical non-small-cell lung cancer (NSCLC) radiotherapy. (2011) (47)
Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer. (2008) (46)
Radiotherapy for pituitary adenomas. (2008) (46)
Radiotherapy for craniopharyngioma (2013) (46)
Radiation-induced hypopituitarism. (2009) (45)
Multiple breath-hold CBCT for online image guided radiotherapy of lung tumors: simulation with a dynamic phantom and first patient data. (2011) (44)
Effective avoidance of a functional spect-perfused lung using intensity modulated radiotherapy (IMRT) for non-small cell lung cancer (NSCLC): an update of a planning study. (2009) (43)
Spinal seeding in cranial germinoma. (1990) (43)
Advice on hair and scalp care during cranial radiotherapy: a prospective randomized trial. (2000) (42)
Salvage radiotherapy in recurrent Hodgkin's disease. (1992) (42)
Haematological toxicity of cranio-spinal irradiation. (1998) (42)
Feasibility of patient immobilization for conventional cranial irradiation with a relocatable stereotactic frame. (1993) (41)
Improvement in tumour control probability with active breathing control and dose escalation: a modelling study. (2009) (41)
Central Nervous System Tumours (2007) (40)
Optimising stereotactic body radiotherapy for non-small cell lung cancer with volumetric intensity-modulated arc therapy--a planning study. (2012) (39)
Clinical controversies: proton radiation therapy for brain and skull base tumors. (2013) (38)
A novel respiratory motion compensation strategy combining gated beam delivery and mean target position concept --a compromise between small safety margins and long duty cycles. (2011) (38)
cis-Diammine-1, 1-cyclobutane dicarboxylate platinum II (carboplatin) in the treatment of testicular germ-cell tumours: a preliminary report. (1985) (37)
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome (2015) (35)
Clinical presentation as a predictor of laparotomy findings in supradiaphragmatic stage I and II Hodgkin's disease. (1986) (34)
Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET (2008) (33)
Comparison of a multi-leaf collimator with conformal blocks for the delivery of stereotactically guided conformal radiotherapy. (1999) (33)
Temozolomide as Second-line Chemotherapy for Relapsed Gliomas (2002) (33)
Fractionated stereotactic conformal radiotherapy for optic nerve sheath meningiomas. (2012) (33)
Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomide (1999) (33)
Radiotherapy for lacrimal gland tumours. (1987) (33)
Verbally administered Barthel Index as functional assessment in brain tumour patients (1997) (33)
To breast feed or not to breast feed. A survey of primiparae. (1976) (32)
Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide. (2005) (32)
Radiotherapy for brain metastases. (2001) (31)
Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement. (1987) (31)
Surveillance following orchidectomy for stage I testicular cancer. (1987) (31)
Position statement on ethics, equipoise and research on charged particle radiation therapy (2013) (30)
Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience. (2000) (30)
Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial (2014) (29)
Clinical trial end points in malignant glioma: need for effective trial design strategy. (2000) (29)
Radiotherapy and radiosurgery for Cushing's disease. (2007) (25)
Radiosurgery/stereotactic external beam radiotherapy for malignant brain tumours: the Royal Marsden Hospital experience. (1994) (25)
Optimal dose of stereotactic radiosurgery for acoustic neuromas: a systematic review (2006) (24)
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer (2018) (23)
Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. (1995) (23)
A comparison of gallium-67 single photon emission computed tomography and computed tomography in mediastinal Hodgkin's disease. (1992) (22)
SABR in NSCLC--the beginning of the end or the end of the beginning? (2015) (22)
Craniopharyngioma revisited. (1993) (21)
Enteropathy associated T cell lymphoma presenting as an isolated CNS lymphoma three years after diagnosis of coeliac disease: T cell receptor polymerase chain reaction studies failed to show the original enteropathy to be a clonal disorder. (1997) (20)
New developments in intracranial stereotactic radiotherapy for metastases. (2015) (20)
ESTRO ACROP guideline for target volume delineation of skull base tumors. (2020) (19)
Fractionated stereotactic external beam radiotherapy in the management of brain metastases. (1993) (19)
EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm. (2008) (19)
Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma. (1995) (19)
Segmentation of IMRT plans for radical lung radiotherapy delivery with the step-and-shoot technique. (2004) (19)
Patient position reproducibility in fractionated stereotactic radiotherapy: an update after changing dental impression material. (1999) (18)
Comparison of setup accuracy and intrafraction motion using stereotactic frame versus 3-point thermoplastic mask-based immobilization for fractionated cranial image guided radiation therapy. (2013) (17)
Radiosurgery for brain tumours (1999) (17)
Stereotactic radiotherapy for solitary brain metastases. (2001) (17)
Back to the future--radiotherapy in high grade gliomas. (1989) (17)
Focal fractionated conformal stereotactic boost following conventional radiotherapy of high-grade gliomas: a randomized phase III study. A joint study of the EORTC (22972) and the MRC (BR10). (1999) (16)
Design and implementation of a system for treating paediatric patients with stereotactically-guided conformal radiotherapy. (2001) (16)
Fractionated stereotactic radiotherapy in the treatment of vestibular schwannoma (acoustic neuroma): predicting the risk of hydrocephalus. (2011) (15)
Stage III Hodgkin's disease--long-term results following chemotherapy, radiotherapy and combined modality therapy. (1989) (15)
Whole body doses from linear accelerator-based stereotactic radiotherapy. (1997) (15)
The management of early‐stage aggressive non‐Hodgkin's lymphoma (1988) (15)
Radiotherapy results in laparotomy-staged Hodgkin's disease. (1988) (15)
Stereotactic Linear Accelerator Radiotherapy for Pituitary Tumors (2004) (15)
Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in high grade glioma (HGG)- BR05. (1998) (13)
Changing patterns of relapse in Hodgkin's disease. (1989) (13)
Severe lung toxicity with a weekly low dose chemotherapy regimen in patients with non‐Hodgkin's lymphoma (1988) (13)
BCL2 gene: current relevance to clinical oncology. (1992) (12)
NICE verdict on Temozolomide: where next? (2002) (12)
How effective is radiosurgery for arteriovenous malformations? (2000) (12)
Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin. (1987) (12)
Paediatric brain tumours. (1996) (12)
Chemotherapy of high-grade gliomas: beginning of a new era or the end of the old? (1996) (11)
Hypercalcaemia in patients with disseminated breast cancer. (1990) (11)
The legend of cytomegalovirus and glioblastoma lives on. (2014) (11)
Fluoroscopy as a surrogate for lung tumour motion. (2012) (10)
Tumours of the brain and spinal cord in adults. (2001) (10)
Infradiaphragmatic Hodgkin's disease. (1992) (10)
The authors reply as follows (1997) (10)
Radiosurgery for pituitary adenoma (1999) (10)
Radiotherapy for malignant gliomas in the elderly. (2003) (9)
Towards equity in turbulent Europe ESTRO, European cooperation and the European Commission. (2005) (9)
Radiation therapy in the management of malignant gliomas. (1996) (9)
Advice on hair and scalp care during cranial radiotherapy: a prospective randomized trial (2001) (8)
Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial (2021) (8)
Stereotactic radiotherapy for irregular targets: Comparison between non-coplanar arcs and static non-coplanar conformal beams (1993) (8)
Peripheral blood involvement in non-Hodgkin's lymphoma detected by clonal gene rearrangement as a biological prognostic marker. (1994) (8)
Hodgkin's Disease of the Epididymis and Testis (1989) (8)
Haematological toxicity of radiotherapy following high-dose chemotherapy and autologous bone marrow transplantation in patients with recurrent Hodgkin's disease. (1994) (8)
Current approaches to radiation therapy for malignant gliomas. (1999) (8)
Cerebral haemangiopericytoma treated with conservative surgery and radiotherapy. (2000) (8)
Radiosurgery for brain metastases. (2002) (8)
Improving outcomes in non-small cell lung cancer; population analysis of radical radiotherapy. (2019) (8)
Is current technology improving outcomes with radiation therapy for gliomas? (2014) (8)
Hodgkin's disease during surveillance of stage I testicular teratoma. (1986) (8)
In regard to Huang et al.: Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. IJROBP 2002;52:599-605. (2003) (8)
Spinal metastatic disease. (2001) (7)
Failure of conventionally fractionated radiotherapy to decrease the risk of hemorrhage in inoperable arteriovenous malformations. (1992) (7)
A randomised trial of Procarbazine, CCNU and Vincristine (PCV) vs Temozolomide (5-day or 21-day schedule) for recurrent high grade glioma (MRC BR12, ISRCTN83176944). (2008) (7)
Incidence and evolution of imaging changes on cone-beam CT during and after radical radiotherapy for non-small cell lung cancer. (2019) (7)
The content and efficacy of conventional methods of follow-up in neuro-oncology: the need for new strategies. (1997) (7)
Stereotactic radiation by linear accelerator using a relocatable frame - technique & optimum beam arrangement (1990) (7)
Chapter 16 – Radiotherapy (2012) (7)
Achieving the relocation accuracy of stereotactic frame-based cranial radiotherapy in a three-point thermoplastic shell. (2013) (7)
Proton therapy: the present and the future. (2013) (7)
Radiotherapy for primary and secondary brain tumors (1995) (6)
Improving outcomes in non-small cell lung cancer; optimum dose fractionation in radical radiotherapy matters. (2022) (6)
Effect of food on the oral bioavailability of temozolomide, a new chemotherapeutic agent (1996) (6)
SEMEN CRYOPRESERVATION FOR PATIENTS SURVIVING MALIGNANT DISEASE: IMPLICATIONS OF PROPOSED LEGISLATION (1988) (5)
Central nervous system lymphomas: progress in chemotherapy and radiotherapy. (1995) (5)
What is the cost of cochlear avoidance in pediatric medulloblastoma? evaluation of 3D conformal planning techniques for the posterior fossa boost (2002) (5)
Malignant cerebral glioma (1997) (5)
Integrated treatment of brain metastases. (2019) (4)
Treatment of brain tumours in children less than 3 years of age. (1993) (4)
Cone beam CT verification for active breathing control (ABC)-gated radiotherapy for lung cancer (2014) (4)
A patient's perspective on randomized clinical trials for proton radiotherapy - Reply (2008) (4)
Modifying the Barthel Performance Index Score for use in patients with brain tumours. (1995) (4)
Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study (2020) (4)
Radiosurgery for brain tumours. (1991) (4)
Radiotherapy in malignant glioma. (2006) (4)
Radiotherapy for Pituitary and Hypothalamic Tumours (2013) (4)
233 - A comparison of stereotactically guided conformal radiotherapy (SCRT) for small brain lesions using either lead alloy blocks or standard multi-leaf collimation (1995) (3)
Fractionated external beam stereotactic radiotherapy (SRT) for recurrent glioma (phase I/II story) (1992) (3)
P3.02c-003 TAX-TORC: The novel combination of weekly paclitaxel and the dual mTORC1/2 inhibitor AZD2014 for the treatment of squamous NSCLC. (2017) (3)
Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer (2021) (3)
Repeat ABC-breath Hold Imaging with Cone-beam CT (2010) (3)
Prognostic and predictive markers in recurrent high grade glioma ; results from the BR 12 randomised trial (2014) (3)
Comparison of forward planning with automated inverse planning for three-dimensional conformal radiotherapy of non-small cell lung cancer without IMRT. (2006) (3)
Early stage Hodgkin's disease in adults: which is the correct treatment? (1989) (2)
ACTR-38. A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) (2018) (2)
Prognostic and predictive markers in recurrent high-grade glioma (HGG): Results from the BR12 randomized trial. (2010) (2)
Geometric uncertainties in brain tumour radiotherapy (2003) (2)
Active Breathing Control (ABC) in Radical Radiotherapy of Non-small Cell Lung Cancer (NSCLC) (2007) (2)
Dosimetry of Intralesional 131I-Monoclonal Antibody (MAb) Therapy in Patients with Recurrent High Grade Gliomas (1995) (2)
Improving Outcomes in NSCLC: Optimum Dose Fractionation in Radical Radiotherapy Matters (2)
Radiotherapy of brain tumours: reduced irradiation of normal brain. (1990) (2)
On Equipoise and Emerging Technologies. Authors' reply (2008) (2)
Health-related quality of life (HQL) measurement in patients with brain cancer (Meeting abstract). (1997) (2)
Impact of molecular biology on our understanding of non-Hodgkin lymphoma. (1991) (2)
ENZYME INDUCING ANTIEPILEPTIC DRUGS AND SURVIVAL OF PATIENTS WITH RECURRENT MALIGNANT GLIOMA (2012) (2)
Differential Diagnosis in Neuro-oncology (2001) (2)
The management of gliomas. (1996) (1)
Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in primary CNS lymphoma (PCL)- BR06. (1998) (1)
Radiotherapy for benign brain tumours coming of age; example of vestibular schwannoma. (2013) (1)
Haematological morbidity in patients with Hodgkin's disease treated with radiotherapy following autologous bone marrow transplantation (1993) (1)
Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial (2014) (1)
Pediatric Neuro-oncology: New Trends in Clinical Research (1994) (1)
Monitoring tumour response with proton resonance spectroscopy in low-grade gliomas (2001) (1)
Proffered paper non-Hodgkin's diseasePeripheral blood involvement in non-Hodgkin's lymphoma (NHL) detected by clonal gene rearrangement as a biological prognostic marker (1993) (1)
Intracranial germ cell tumour in association with cryptorchidism. (1992) (1)
Prognostic indices in malignant glioma-matching form to function (2000) (1)
Brain tumors in children--lifetime for patients and investigators. (1995) (1)
Fractionated radiation for meningiomas (2010) (1)
Malignant cerebral glioma. Modern radiotherapy can give good quality survival for six months. (1997) (1)
Technical Aspects of Radiotherapy for Non-small Cell Lung Cancer (NSCLC); a National Survey of Practice (2007) (1)
Radiation injury to the nervous system, P.H. Gutin, S.A. Leibel, G.E. Sheline (Eds.). Raven Press, Berlin Heidelberg New York (1991), 496 (1992) (1)
Hodgkin's disease of the liver; prognosis and possible indications for radiotherapy. (1991) (1)
Response to Dr. Curran (1994) (1)
13 - Brain Metastases (2010) (1)
CANCER NEUROLOGY IN CLINICAL PRACTICE (2003) (1)
Localization in radioimmunotherapy using a stereotactic head frame (1993) (1)
Radiotherapy for acromegaly (2009) (1)
The treatment of malignant cerebral tumours. (2000) (1)
VISUAL: Clinical implementation of volumetric modulated arc therapy (VMAT) image-guided stereotactic radiotherapy using active breathing control (ABC) for small volume lung tumours (2010) (1)
Volume Contents (2004) (0)
Radiosurgery - an alternative view (1997) (0)
Molecular neuro-oncology: new avenues in diagnosis and treatment (2012) (0)
TAX-TORC: A phase I trial of vistusertib (AZD2014) in combination with weekly paclitaxel with integrated pharmacodynamic (PD) and molecular characterization (MC) studies. (2017) (0)
6552 POSTER Quantitative evaluation of dyspnoea after radiotherapy of non-small cell lung cancer: a prospective study (2007) (0)
REDUCING SYSTEMATIC AND RANDOM ERRORS OF CRANIAL RADIOTHERAPY IN A THERMOPLASTIC SHELL WITH EXACTRAC (2009) (0)
Development and Use of a Multi-Wire Proportional Chamber Positron Camera at a Clinical Site without a Cyclotron (1992) (0)
The impact of brain metastases on the clinical service in a cancer center. (2013) (0)
Long-Term Efficacy of Fractionated Stereotactic Radiotherapy for Benign Meningiomas (2012) (0)
A Year of Continued Growth and Success (2012) (0)
P-736 Modern radical non-small cell lung cancer (NSCLC) radiotherapy:Combining complex conformal techniques with movement control (2005) (0)
EP-1327: The definition of an auditable and complete dataset for lung cancer patients - the RTTís role (2015) (0)
Health-Related Qual i ty of Li fe in Pat ients Treated With Temozolomide Versus Procarbaz ine for Recurrent Gl ioblas toma Mult i forme (2000) (0)
Rare Cancers (Reply to Dr B. Jones) (2000) (0)
MA17.07 Nurse-Led Telehealth Clinic in Treatment Monitoring and Follow Up (2018) (0)
M. Prados (ed). Brain Cancer (2002) (0)
Focused radiotherapy as primary treatment for pituitary disease (2011) (0)
The Management of Lung Cancer, John F. Smyth (Ed.). Edward Arnold, London (1984) (1985) (0)
Somnolence syndrome: Toxicity of cranial irradiation (1996) (0)
Radiotherapy and radiosurgery for Cushing ' s disease , Arquivos Brasileiros (2010) (0)
393 INVITED Combination of Radiotherapy and Targeted Agents – What Should We Expect? (2011) (0)
Book reviews (2004) (0)
Annual Report ( 2016 cohort ) The Clatterbridge Cancer Centre NHS FT ( REN ) Tertiary Trust Cheshire and Merseyside Strategic Clinical Network Clinical Lead : (0)
High precision focused irradiation in the form of fractionated stereotactic conformal radiotherapy (SCRT) for benign meningiomas skull base predominantly in the location (2002) (0)
Reply to gamma unit manufacturer (2017) (0)
48. Detection of recurrent/remnant glioma after cerebral radiotherapy using 18F-FDG PET (1993) (0)
A systematic review of hypofractionated small volume radiotherapy for early stage non-small cell lung cancer (NSCLC) (2010) (0)
4A rotating couch-top system for the planning and delivery of stereotactically guided conformal radiotherapy (1996) (0)
In regard to Huang et al.: Intensity-Modulated radiaton therapy for pediatric medulloblastoma: Early report on the reduction of ototoxicity IJROBP 2002;52:599-605 [5] (multiple letters) (2003) (0)
Harmful effects of radiation on the nervous system (2002) (0)
144 Distribution kinetics of radiolabelled monoclonal antibodies (MAB) in experimental tumours following interstitial and systemic administration (1995) (0)
8519 POSTER DISCUSSION Setup Margins in a Thermoplastic Shell Can Be Reduced to Those of a Stereotactic Frame Using Daily Online Correction – a Prospective Comparison Between Shell and Frame (2011) (0)
Offi cial publication of the Association of Radiation Oncologists of India (2007) (0)
Intensity-modulated radiation therapy for pediatric medulloblastoma: Early report on the reduction of ototoxicity. Authors' reply (2003) (0)
Phase I study of afatinib and radiotherapy (RT) with or without temozolomide (TMZ) in newly diagnosed glioblastoma (GB). (2018) (0)
Cranial Ependymoma (Chapter 41) (2009) (0)
A brain cancer clinical assessment tool (BC CAT) for monitoring disease status in high-grade gliomas (1999) (0)
High grade gliomas - how effective is radiotherapy? (2003) (0)
Backtothefuture - radiotherapy inhigh grade gliomas (1989) (0)
Health-Related Q uality o f L ife i n P atients T reated W ith Temozolomide V ersus P rocarbazine f or R ecurrent Glioblastoma M ultiforme (2000) (0)
Multimodal Image Registration for Radioimmunotherapy. Surface Landmark and Frame Based Correlation in Patients Undergoing Intralesional 131I-MAb Therapy for Recurrent High Grade Glioma (1995) (0)
Stereotactic radiotherapy for brain tumours-fact & fiction (1997) (0)
Medical research council adjuvant trial in high-grade gliomas - In Reply (2001) (0)
Robust Comprehensive Dataset Provides Pause for Thought. (2022) (0)
educational session Brain tumors (2006) (0)
Radiotherapy treatment margins for non-small cell lung cancer (NSCLC): Controlling tumour motion with active breathing control (ABC) cannot be considered in isolation (2006) (0)
81 Does radiotherapy matter (2003) (0)
Comparison of Interlesionally and Systemically Administered Radiolabelled Monoclonal Antibodies in Implanted Tumours (1999) (0)
319Conformal therapy in the treatment of brain tumours (1996) (0)
Can the Accuracy of a Stereotactic Frame be Achieved Using a Thermoplastic Shell (2011) (0)
[Efficacy and safety of vildagliptin as a second-line therapy vs other oral antidiabetic agents in patients with type 2 diabetes: Czech results within the worldwide prospective cohort EDGE study]. (2013) (0)
Tumour-directed Theraphy in Neuro-oncology (1991) (0)
Non-Curative Radiotherapy for Neurological Cancer (1998) (0)
Abstracts from meeting 23 October 1992 (1993) (0)
Conventional Radiotherapy for Pituitary Adenomas (2003) (0)
Fractionated stereotactic conformal radiotherapy for skull base benign tumours: an endocrinological follow-up (2007) (0)
Optimizing stereotactic radiotherapy for irregular targets (1993) (0)
475 poster ACHIEVING THE PRECISION OF STEREOTACTIC FRAME-BASED CRANIAL RADIOTHERAPY IN A THERMOPLASTIC SHELL (2011) (0)
2064 POSTER Comparing Volumetric Intensity Modulated Arc Therapy With Multiple Static Field Radiosurgery for Brain Metastases (2011) (0)
Methods of intervention in reducing the psychosocial impact while dealing with cancer as a disease : A clinician ’ s point of view (2007) (0)
Brain Metastasis: Challenges in Understanding Pathogenesis and in Designing Clinical Trials (2012) (0)
103. The effect of conventional cerebral irradiation on blood???brain barrier (BBB) permeability (1992) (0)
P84 On-line Image Verification for Prostate Radiotherapy d is Daily (2011) (0)
Chapter 138. Brain Metastases (2010) (0)
Optimisation of lung radiotherapy planning using accurate co-registration of planning CT and spect perfusion images (2003) (0)
OC-0307 Feasibility of cardiac sparing in isotoxic dose escalated radiotherapy for NSCLC (2019) (0)
Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer (2021) (0)
Multicenter P hase I I T rial o f T emozolomide i n P atients With A naplastic A strocytoma o r A naplastic Oligoastrocytoma a t F irst R elapse (1999) (0)
Controversies in the management of metastatic spinal cord compression. (1996) (0)
Intrafractional movement of the oesophagus in patients with Non-Small Cell Lung Cancer (NSCLC) (2005) (0)
Book reviewsBrain Tumors in Children—Principles of Diagnosis and Treatment (2nd edn). Ed.by CohenM E and DuffnerP K, pp. 512, 1993 (Raven Press, New York), $125.00. ISBN 0781700647 (1995) (0)
Radiotherapy for Malignant Brain Tumours (1995) (0)
Autologous bone marrow transplantation and radiotherapy in patients with Hodgkin's disease (1993) (0)
Brain Cancer Module 20 (2018) (0)
Abstracts for the Tenth International Conference on Brain Tumour Research and Therapy (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael Brada?

Michael Brada is affiliated with the following schools:

Michael Brada's Academic­Influence.com Rankings

Michael Brada's Degrees

Why Is Michael Brada Influential?

Michael Brada's Published Works

Published Works

What Schools Are Affiliated With Michael Brada?

Michael Brada's AcademicInfluence.com Rankings